Clinical trial

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

NCT00634205

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE2

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2015-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malignant Mesotheliomaunresolved

Interventions

Valproate plus doxorubicinDRUG

Sponsors & collaborators

European Lung Cancer Working Partylead sponsor

Mapped research locations

BrusselsBelgium2 LilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00634205 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.